Janney Montgomery Scott LLC Has $1.18 Million Stock Position in Humana Inc. (NYSE:HUM)

Janney Montgomery Scott LLC raised its position in shares of Humana Inc. (NYSE:HUM) by 11.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,721 shares of the insurance provider’s stock after purchasing an additional 388 shares during the period. Janney Montgomery Scott LLC’s holdings in Humana were worth $1,179,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in HUM. Avantax Advisory Services Inc. increased its holdings in shares of Humana by 11.2% during the first quarter. Avantax Advisory Services Inc. now owns 2,721 shares of the insurance provider’s stock worth $943,000 after buying an additional 275 shares in the last quarter. HBK Sorce Advisory LLC acquired a new position in shares of Humana during the first quarter worth $304,000. Orion Portfolio Solutions LLC increased its holdings in shares of Humana by 17.3% during the first quarter. Orion Portfolio Solutions LLC now owns 4,299 shares of the insurance provider’s stock worth $1,490,000 after buying an additional 634 shares in the last quarter. Dorsey & Whitney Trust CO LLC increased its holdings in shares of Humana by 22.1% during the first quarter. Dorsey & Whitney Trust CO LLC now owns 983 shares of the insurance provider’s stock worth $341,000 after buying an additional 178 shares in the last quarter. Finally, M&G Plc acquired a new position in shares of Humana during the first quarter worth $5,622,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. TD Cowen upped their price target on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a report on Monday, November 4th. JPMorgan Chase & Co. increased their price objective on Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. Truist Financial decreased their price objective on Humana from $400.00 to $260.00 and set a “hold” rating for the company in a report on Friday, October 11th. Stephens restated an “equal weight” rating and issued a $250.00 price objective on shares of Humana in a report on Wednesday, October 9th. Finally, Piper Sandler downgraded Humana from an “overweight” rating to a “neutral” rating and decreased their price objective for the company from $392.00 to $274.00 in a report on Thursday, October 3rd. Twenty investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, Humana has an average rating of “Hold” and an average target price of $315.86.

Humana Stock Performance

Shares of HUM opened at $275.67 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The stock has a 50-day moving average of $283.00 and a 200-day moving average of $331.80. The company has a market cap of $33.19 billion, a PE ratio of 24.47, a P/E/G ratio of 2.29 and a beta of 0.52. Humana Inc. has a one year low of $213.31 and a one year high of $527.18.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. On average, equities research analysts predict that Humana Inc. will post 15.83 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a dividend yield of 1.28%. Humana’s dividend payout ratio is presently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.